Search research articles
Contact Us
Filters
Showing results (21-30 of 105) with videos related to
Page
of 11
Sort By:
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 1, 1997
The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin. (Rapid communication)
P Martin, N Waters, A Carlsson, et al.
The Science of the Total Environment
|
May 3, 2021
Alterations to sediment nutrient deposition and transport along a six reservoir sequence
B C Webster, M N Waters, S W Golladay
Brain Research. Brain Research Reviews
|
March 17, 2000
Network interactions in schizophrenia - therapeutic implications
A Carlsson, N Waters, S Waters, et al.
Journal of Medicinal Chemistry
|
August 4, 1995
On the quantitative structure-activity relationships of meta-substituted (S)-phenylpiperidines, a class of preferential dopamine D2 autoreceptor ligands: modeling of dopamine synthesis and release in vivo by means of partial least squares regression
L O Hansson, N Waters, S Holm, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 1, 1996
Effects on locomotor activity after local application of (+)-UH232 in discrete areas of the rat brain
T Kling-Petersen, E Ljung, N Waters, et al.
Biochimica Et Biophysica Acta
|
February 28, 1973
Kinetics of the clearing of 14 C-labeled deoxyribonucleosides from rat blood in vivo and in vitro
R E Beltz, T R Smith, R N Waters
Water Research
|
August 22, 2024
Linking reservoir annual residence time to nitrogen deposition using paleolimnological techniques
Benjamin C Webster, Matthew N Waters, Stephen W Golladay
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 1, 1996
Concurrent locomotor stimulation and decrease in dopamine release in rats and mice after treatment with the competitive NMDA receptor antagonists D-CPPene and CGS 19755
N Waters, C Lundgren, L O Hansson, et al.
Neurology
|
October 26, 1999
Long-lasting improvement following (-)-OSU6162 in a patient with Huntington's disease
J Tedroff, A Ekesbo, C Sonesson, et al.
Life Sciences
|
January 1, 1997
Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications
A Carlsson, L O Hansson, N Waters, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 105) with videos related to
Sort By:
Page
of 11
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 1, 1997
The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin. (Rapid communication)
P Martin, N Waters, A Carlsson, et al.
The Science of the Total Environment
|
May 3, 2021
Alterations to sediment nutrient deposition and transport along a six reservoir sequence
B C Webster, M N Waters, S W Golladay
Brain Research. Brain Research Reviews
|
March 17, 2000
Network interactions in schizophrenia - therapeutic implications
A Carlsson, N Waters, S Waters, et al.
Journal of Medicinal Chemistry
|
August 4, 1995
On the quantitative structure-activity relationships of meta-substituted (S)-phenylpiperidines, a class of preferential dopamine D2 autoreceptor ligands: modeling of dopamine synthesis and release in vivo by means of partial least squares regression
L O Hansson, N Waters, S Holm, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 1, 1996
Effects on locomotor activity after local application of (+)-UH232 in discrete areas of the rat brain
T Kling-Petersen, E Ljung, N Waters, et al.
Biochimica Et Biophysica Acta
|
February 28, 1973
Kinetics of the clearing of 14 C-labeled deoxyribonucleosides from rat blood in vivo and in vitro
R E Beltz, T R Smith, R N Waters
Water Research
|
August 22, 2024
Linking reservoir annual residence time to nitrogen deposition using paleolimnological techniques
Benjamin C Webster, Matthew N Waters, Stephen W Golladay
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 1, 1996
Concurrent locomotor stimulation and decrease in dopamine release in rats and mice after treatment with the competitive NMDA receptor antagonists D-CPPene and CGS 19755
N Waters, C Lundgren, L O Hansson, et al.
Neurology
|
October 26, 1999
Long-lasting improvement following (-)-OSU6162 in a patient with Huntington's disease
J Tedroff, A Ekesbo, C Sonesson, et al.
Life Sciences
|
January 1, 1997
Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications
A Carlsson, L O Hansson, N Waters, et al.
Page
of 11